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Somatostatin (SS) and allatostatin-C (ASTC) are structurally and evolutionarily
related neuropeptides that act as inhibitory regulators of physiological pro-
cesses in mammals and insects, respectively. Here, we report the first
molecular and functional characterization of SS/ASTC-type signalling in a
deuterostome invertebrate—the starfish Asterias rubens (phylum Echinoder-
mata). Two SS/ASTC-type precursors were identified in A. rubens (ArSSP1
and ArSSP2) and the structures of neuropeptides derived from these
proteins (ArSS1 and ArSS2) were analysed using mass spectrometry. Pharma-
cological characterization of three cloned A. rubens SS/ASTC-type receptors
(ArSSR1–3) revealed that ArSS2, but not ArSS1, acts as a ligand for all three
receptors. Analysis of ArSS2 expression in A. rubens using mRNA in situ
hybridization and immunohistochemistry revealed stained cells/fibres in the
central nervous system, the digestive system (e.g. cardiac stomach) and the
body wall and its appendages (e.g. tube feet). Furthermore, in vitro pharmaco-
logical tests revealed that ArSS2 causes dose-dependent relaxation of tube foot
and cardiac stomach preparations, while injection of ArSS2 in vivo causes
partial eversion of the cardiac stomach. Our findings provide new insights
into the molecular evolution of SS/ASTC-type signalling in the animal king-
dom and reveal an ancient role of SS-type neuropeptides as inhibitory
regulators of muscle contractility.1. Introduction
Somatostatin (SS)was first identified as a constituent of rat hypothalamus that inhi-
bits growth hormone release [1] and a constituent of pigeon pancreatic islets that
inhibits insulin release [2]. Purification and sequencing of SS revealed that it is a tet-
radecapeptidewithadisulfidebridge linking cysteine residuesatpositions3and14
(SS14) [3]. Subsequently, an N-terminally extended isoform (SS28) was identified
[4], with both SS14 and SS28 being derived from the same precursor protein [5].
Five G-protein-coupled receptors, SSTR1, SSTR2, SSTR3, SSTR4 and SSTR5, med-
iate effects of SS in mammals as a regulator of a variety of physiological processes
[6,7]. In addition to its effects as an inhibitor of hormone release, other actions of SS
inmammals include inhibitionofpancreatic exocrine secretion [8], regulationofgut
motility [8,9] and neuromodulation in the central nervous system [10,11]. Behav-
ioural effects of intracerebroventricular administration of SS in mammals include
stimulation of food intake and drinking [12,13] and anxiolysis [14].
The neuropeptides cortistatin (CST), urotensin II (UII) and urotensin II-
related peptide (URP) share sequence similarity with SS, including the presence
of two cysteines that form a disulfide bridge, indicating that these peptides have
a common evolutionary origin [15]. Accordingly, analysis of the phylogenetic
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2distribution of these neuropeptides in vertebrates indicates
that tandem gene duplication gave rise to genes encoding an
SS/CST-type peptide and a UII/URP-type peptide. Then
two or three rounds of genome duplication followed by differ-
ential gene loss gave rise to the variable numbers of genes
encoding SS/UII-type peptides in different vertebrate
lineages, ranging from four genes in humans (SS, CST, UII,
URP) to as many as eleven genes in the zebrafish Danio rerio.
Likewise, variable numbers of receptors for SS/UII-type pep-
tides are found in different vertebrate lineages [15]; in humans,
for example, in addition to five receptors thatmediate effects of
SS and CST, there is a single receptor that mediates effects of
UII and URP [16,17]. Other GPCRs that are closely related to
SS receptors have also been identified in vertebrates and deor-
phanization has revealed thatmelanin-concentrating hormone
(MCH) acts as a ligand for these receptors. Consistent with this
finding, MCH shares structural similarity with SS in having
two cysteine residues that form a disulfide bridge in the
mature peptide [18,19].
Phylogenetic analysis of neuropeptide signalling through-
out the animal kingdom has revealed relationships between
neuropeptides in vertebrates and invertebrates, with the evol-
utionary origin of at least 30 neuropeptide systems being
traced back to the common ancestor of the Bilateria [20].
Accordingly, allatostatin-C (ASTC) type neuropeptides and
their receptors in protostome invertebrates are recognized as
homologues of vertebrate SS-type peptides and their receptors,
respectively [21,22]. ASTC was first identified in the insect
Manduca sexta on account of its inhibitory effect on juvenile hor-
mone biosynthesis, with structural characterization revealing
that it is a 15-residue peptide with a disulfide bridge formed
by two cysteine residues [23]. Subsequently, ASTC-type pep-
tides were identified in other insect species and the receptors
that mediate effects of ASTC were identified in Drosophila mel-
anogaster. Furthermore, discovery of these receptors revealed
that ASTC-type receptors in insects are closely related to
SS-type receptors and opioid-type receptors in vertebrates
[21]. Subsequently, a paralogue of ASTC named allatostatin
double C (ASTCC) was identified in D. melanogaster [24] and
ASTC-like peptides were identified in other protostome invert-
ebrates, including molluscs [25–28] and annelids [29].
Investigation of the physiological roles of ASTC-type
signalling in D. melanogaster has revealed roles in cardio-
inhibition [30], anti-nociception, immunosuppression [31]
and regulation of circadian activity [32]. Furthermore, inves-
tigation of ASTC-type neuropeptide function in other
arthropods has revealed roles in inhibition of gut myoactivity
and suppression of feeding/growth in the tomato moth
Lacanobia oleracea [33,34] and in the pea aphid Acyrthosiphon
pisum [35], modulation of learning in bees [36,37], inhibitory
regulation of post-prandial heart and gut activity in the
blood-sucking bug Rhodnius prolixus [38], regulation of
cardiac and foregut activity in the lobster Homarus americanus
and the crab Cancer borealis [39–43], and inhibition of ovarian
development in the mud crab Scylla paramamosain [44]. To the
best of our knowledge, however, nothing is known about the
physiological roles of ASTC-type neuropeptides in other
protostomes (e.g. molluscs, annelids).
Important insights into the evolution and comparative
physiology of neuropeptide signalling systems have been
obtained from research on deuterostome invertebrates (e.g. uro-
chordates, echinoderms), which are more closely related to
vertebrates than protostome invertebrates [45–47]. Accordingly,by analysing transcriptome/genome sequence data from echi-
noderms, we recently reported the discovery of precursor
proteins that comprise peptides that share sequence similarity
with SS/ASTC-type neuropeptides [48,49]. However, the recep-
tors that mediate the effects of echinoderm SS/ASTC-like
peptides have not been identified. Furthermore, nothing is
known about the expression and physiological roles of SS/
ASTC-like neuropeptides in echinoderms. Therefore, here
we used the starfish A. rubens as an experimental system to
address this issue. This is the first study to report the molecular
and functional characterization of SS-type signalling in a
deuterostome invertebrate.2. Material and methods
2.1. Animals
Starfish (A. rubens) were collected at low tide near Margate
(Kent, UK) or were obtained from a fisherman based in Whit-
stable (Kent, UK), and then transported to an aquarium
located in the School of Biological and Chemical Sciences
at Queen Mary University of London. Here, the animals
were maintained in circulating artificial seawater (Premium
Reef-Salt, Tropical Marine Centre, Rickmansworth, UK) at a
salinity of 32‰ and at a temperature of approximately
12°C under a 12 h/12 h light/dark cycle. The starfish were
fed on mussels (Mytilus edulis) that were also collected near
Margate (Kent, UK) at low tide.
2.2. Cloning and sequencing of cDNAs encoding
A. rubens precursors of SS-like peptides
Two transcripts encoding precursors of SS-like peptides were
identified by analysis of A. rubens neural transcriptome
sequence data—ArSSP1 (GenBank: KT601708) and ArSSP2
(GenBank: MN257487). The sequence of ArSSP1 has been
reported previously [48]. The sequence of ArSSP2 is reported
here for the first time and was identified on account of its simi-
larity to precursors of SS-like peptides that have been identified
in other echinoderms [49]. Informed by the assembled tran-
script sequences of ArSSP1 and ArSSP2, cDNAs comprising
the complete open reading frame of ArSSP1 and ArSSP2
were amplified from A. rubens radial nerve cord cDNA by
PCR using specific primers (electronic supplementary
material, table S1) and Q5 High-fidelity DNA polymerase
(NEB, Hitchin, UK; cat. no. M0491S), cloned into pBluescript
II SK+ vector (Agilent Technologies, Santa Clara, USA; cat.
no. 212205) and then sequenced (TubeSeq service; Eurofins
Genomics, Ebersberg, Germany).
2.3. Structural characterization of the ArSSP1- and
ArSSP2-derived neuropeptides ArSS1 and ArSS2
in extracts of A. rubens radial nerve cords using
mass spectrometry
Extracts of A. rubens radial nerve cords were prepared and
analysed using mass spectrometry (NanoLC-ESI-MS/MS)
as described in detail previously for A. rubens relaxin-like
gonad-stimulating peptide, a neuropeptide that contains
disulfide bridges [50]. Because both ArSS1 and ArSS2 are
royalsocietypublishing.org/journal/rsob
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3predicted to contain a disulfide bridge, samples of extracts
were treated with dithiothreitol (DTT) for reduction to break
disulfide bridges and then were treated with iodoacetamide
to alkylate cysteine residues. For comparison, samples of
extracts without reduction and alkylation were also analysed.
2.4. Sequence alignment of echinoderm SS-like
peptides with SS-related peptides in other taxa
The amino acid sequences ofArSS1 andArSS2 and related pep-
tides from other echinoderms were aligned with the sequences
of SS-related neuropeptides from a variety of bilaterian species
(see electronic supplementary material, table S2 for a list of the
sequences). This was accomplished using MAFFT 7, with the
iterative refinement method set to L-INS-i and scoring matrix
for amino acid sequences set to BLOSUM62, ensuring an opti-
mal alignment. BOXSHADE software (https://embnet.vital-it.
ch/software/BOX_form.html) was used to highlight residues
that are identical or are conservative substitutions in at least
70% of the aligned sequences.
2.5. Comparison of the exon/intron structure of genes
encoding SS-like peptides in echinoderms and
other taxa
The sequences of transcripts and genes encoding precursors
of SS-related peptides were obtained from the NCBI GenBank
database (see electronic supplementary material, table S3 for
a list of the transcript and gene sequences used). The online
tool Splign [51] was used to determine gene structure and
IBS 1.0 [52] was used to generate diagrams of gene structures.
2.6. Identification of candidate SS-type receptors in
A. rubens and phylogenetic analysis of their
relationship with related receptors in other
bilaterians
BLAST analysis of an A. rubens neural transcriptome sequence
database [48,53] was performed to identify transcripts
encoding candidate SS-type receptors. To accomplish this,
SequenceServer [54] was used, submitting sequences of SS-
type receptors from Homo sapiens (GenBank; NP_001040.1,
NP_001041.1, NP_001042.1, NP_001043.2, NP_001044.1),
ASTC-type receptors from D. melanogaster (GenBank;
NP_001027135.2, NP_649040.2), MCH-type receptors from
H. sapiens (GenBank; NP_005288.3, NP_001035269.1) as
query sequences. Five transcripts were identified as the top
hits in all BLAST searches and the five encoded protein
sequences were analysed using Protter v. 1.0 to determine
the locations of predicted membrane-spanning domains and
other structural features [55]. Using BLAST, homologues
of the A. rubens receptor proteins were identified in other echi-
noderms, including the starfish Acanthaster planci, the brittle
star Ophionotus victoriae, the sea urchin Strongylocentrotus
purpuratus and the sea cucumber Apostichopus japonicus.
Relationships of the five A. rubens receptors with closely
related receptors in other taxa typeswere investigated by align-
ment with SS/ASTC/opioid-type, MCH-type and urotensin
II-type receptors, using galanin-type and kisspeptin-type
receptors as outgroups (see electronic supplementary material,table S4 for a list of sequences, which were obtained from the
NCBI GenBank database). Alignments were generated using
the MUSCLE algorithm in MEGA 7 (iterative, 10 iterations,
UPGMB as clustering method) [56,57]. Next the alignment
was manually trimmed N-terminally and C-terminally to pro-
duce an alignment of 396 residues (including gaps) spanning
from the beginning of the predicted first transmembrane
domain to end of the seventh transmembrane domain.
Then the maximum-likelihood method was used to generate
a phylogenetic tree using W-IQ-tree online version 1.0 (1000
bootstrap replicates, LG + F+I + G4 substitution model) [57]
and a graphic of the phylogenetic tree was produced using
FigTree v. 1.4.4 [58]. A second alignment was manually
trimmed in the regions where only one sequence did not
align with any other sequence. This version had less trimming
of the sequences compared with the first alignment and
included a total of 523 residues (including gaps) spanning
from the first to the seventh transmembrane domains; a phylo-
genetic tree was then generated as described above for the first
alignment (see electronic supplementary material, figure S5).2.7. Pharmacological characterization of A. rubens
SS-type receptors
Three cDNAs encoding SS-type receptors were amplified from
A. rubens radial nerve cord total cDNA by PCR, using specific
primers (see electronic supplementary material, table S1) and
Q5 High-fidelity DNA polymerase (NEB, Hitchin, UK; cat. no.
M0491S). PCR products comprising the complete open reading
frame with a partial Kozak consensus sequence (ACC) before
theATG start codon [59]were phosphorylated usingT4polynu-
cleotide kinase for 2 h (Thermo Fisher Scientific, Oxford, UK;
cat. no. EK0031) and then purified using a QIAquick gel extrac-
tion kit (Qiagen, Hilden, Germany; cat. no. 28704). Before blunt
cloning PCR products into the expression vector pcDNA3.1+
(Invitrogen, Oxford, UK; cat. no. v. 790–20) using T4 DNA
ligase (NEB, Hitchin, UK; cat. no. M0202S), the pcDNA3.1+
vector was cut with the restriction enzyme EcoRV-HF (NEB,
Hitchin, UK; cat. no. R3195T) and processed with ShrimpAlka-
line Phosphatase (NEB, Hitchin, UK; cat. no. M0371S) to avoid
vector self-ligation. Successful cloning of cDNAswas confirmed
by PCR and sequencing (TubeSeq service, Eurofins Genomics,
Ebersberg, Germany).
In order to characterize the candidate SS-type receptors, a
G-protein-dependent receptor activation assay was employed
[60]. Chinese hamster ovary (CHO)-K1 cells stably over-
expressing the calcium-sensitive bioluminescent reporter
GFP-aequorin fusion protein (G5A) were used as a heterolo-
gous expression system [61]. Plasmids containing A. rubens
SS-type receptor cDNAs were co-transfected with the pro-
miscuous human Gα16, which is widely used for receptor
deorphanization assays [62]. Firstly, CHO-K1 cells were
cultured at 37°C with 5% carbon dioxide (CO2) in a culture
medium comprising DMEM/F12, 10% fetal bovine serum,
Antibiotic-Antimycotic 1x, and 200 µg ml−1 of Geneticin
G418 sulfate (all purchased from Thermo Fisher Scientific,
Oxford, UK; cat. no. 11039047, 10082147, 15240062 and
10131035, respectively). Upon reaching confluency of approxi-
mately 80%, cellswere co-transfectedwith plasmids containing
anA. rubens SS-type receptor cDNA andGα16 using Lipofecta-
mine 3000 (Thermo Fisher Scientific, Oxford, UK; cat. no.
L3000008). Cells transfected with the empty pcDNA3.1+
royalsocietypublishing.org/journal/rsob
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4vector were used as a negative control. A detailed description
of the method used for this assay has been described for deor-
phanization of luqin-type receptors in A. rubens [63]. Forty-
eight hours after transfection, cells were detached by using
PBS buffer pH 7.4 (Thermo Fisher Scientific, Oxford, UK; cat.
no. 10010023) supplemented with a final concentration of
5 mM EDTA pH 8.0 (Thermo Fisher Scientific, Oxford, UK;
cat. no. 15575020). Cells were washed with DMEM/F12
buffer and then incubated with 1 mM coelenterazine-H
(Thermo Fisher Scientific, Oxford, UK; cat. no. C6780) at
room temperature for 3 h. During the incubation time, syn-
thetic ArSS1 or ArSS2 (custom synthesized by Peptide
Protein Research Ltd; Fareham, UK) diluted in DMEM/F12
medium at concentrations ranging from 10−21 to 10−4 M were
pipetted into clear bottom 96-well plates sequentially (Sigma-
Aldrich, Gillingham, UK; cat. no. CLS3603-48EA). After 3 h
incubation, a fixed volume of cells was injected sequentially
into each well containing different concentrations of peptides
using a FLUOstar Omega Plate Reader (BMG LABTECH,
Ortenberg, Germany). Luminescence values were recorded
over a 35 s period after injection. The total luminescence of
each well over the 35 s period was calculated and normalized
to themaximumvalue obtained in each experiment (100% acti-
vation) and to the value obtained with the vehicle media (0%
activation). Dose–response curves were fitted with a four-par-
ameter curve using Prism 6 (GraphPad, La Jolla, CA, USA)
based on data collected from at least three independent trans-
fections and three repeats per experiment. EC50 values were
calculated fromdose–response curves using Prism 6. The lumi-
nescence responses triggered by 10−5 M ArSS1, 10−5 M ArSS2
and vehicle media were analysed by one-way ANOVA using
Bonferroni’s multiple comparisons post hoc test in Prism 6.2.8. Localization of ArSSP2 expression in A. rubens
using mRNA in situ hybridization
ArSSP2 cDNAwas amplified by PCR from a pBluescript II SK+
plasmid containing the cloned ArSSP2 cDNA using
standard M13 primers (see electronic supplementary material,
table S1) andQ5High-fidelity DNApolymerase (NEB,Hitchin,
UK; cat. no. M0491S). Then PCR products were purified
using the QIAquick gel extraction kit (Qiagen, Hilden,
Germany; cat. No. 28704). Antisense and sense probes were
generated by incubating the purified PCR product with
digoxigenin (DIG)-labelled nucleotide triphosphate mix
(Roche, Hertfordshire, UK; cat. no. 11277073910) supplemented
with dithiothreitol (Promega, Hampshire, UK; cat. no. P1171),
placental ribonuclease inhibitor (NEB, Hitchin, UK; cat. no.
M0307S), T3 or T7 RNA polymerase with transcription buffer
(NEB, Hitchin, UK, cat. no. M0251S) at 37°C for 2 h. The DNA
templates were digested with RNAse-free DNAse (NEB,
Hitchin, UK; cat. no. M0303S) at 37°C for 30 min and then the
labelled RNA probes were precipitated and stored in 25%
formamide made up in 2× saline-sodium citrate (SSC) buffer
at −20°C.
Small (diameter 4–8 cm) or medium (diameter 8–12 cm)
sized adult specimens of A. rubens were fixed in 4% parafor-
maldehyde (PFA; Sigma-Aldrich, Gillingham, UK) for at least
24 h at 4°C. The specimens were washed in autoclaved
distilled water and then dissected to separate arms from the
central disc region. Morse’s solution (10% sodium citrate
and 20% formic acid dissolved in autoclaved water) wasused to decalcify the arms and central disc of the starfish at
room temperature for at least 3 and 8 h, respectively, with
the Morse’s solution replenished every 2 h. Then the decalci-
fied tissues were washed in autoclaved water and dehydrated
sequentially in 50, 70, 90 and 100% ethanol. After clearing in
xylene (3 × 5 min), the tissues were transferred to melted
filtered paraffin wax (three changes) at approximately 60°C,
and then embedded in wax at room temperature. Sections
of arms/discs (14 µm) were prepared using a microtome
(RM 2145, Leica Microsystems, Milton Keynes, UK), mounted
over water on Poly-L-lysine coated microscope slides (Poly-
sine; VWR, Lutterworth, UK) and then left to dry overnight
at room temperature.
Prior to mRNA in situ hybridization, xylene was used to
remove the paraffin wax (three changes) and then an ethanol
series (100, 90, 70, 50, 30%) followed by PBS was used to
rehydrate the sections. Next the sections were fixed in 4%
PFA/PBS, followed by washing in PBS/0.1% Tween-20
(PBST). After incubation with Proteinase K (Qiagen, Hilden,
Germany) at 37°C, the sections were fixed in 4% PFA/PBS
and washed again in PBST. To reduce non-specific back-
ground staining, sections were acetylated (1.3%
triethanolamine, pH 7–8; 0.25% acetic anhydride; 0.18%
acetic acid; (VWR Chemicals, Lutterworth, UK) made up in
distilled water) and then following washing in PBST and 5
x SSC solution, the sections were pre-hybridized in hybridiz-
ation buffer (50% formamide (Amresco, Solon, USA); 5 x SSC;
500 µg ml−1 yeast total RNA (Sigma-Aldrich, Gillingham,
UK); 50 µg ml−1 heparin (Sigma-Aldrich, Gillingham, UK);
0.1% Tween-20 in distilled water) for 2 h. Antisense or
sense probes (500 ng m−1) were denatured at 80°C for 2 min
and then approximately 100 µl was added to each slide,
which was then covered with Parafilm (Bemis, Terre Haute,
USA) to reduce evaporation. The slides were placed in
humidified chambers and incubated at 60°C overnight. On
the second day, the slides were washed in 0.2 x SSC, equili-
brated in Buffer B1 (10 mM Tris–HCl (pH 7.5); 150 mM
NaCl in autoclaved water) and blocked in 5% goat serum/
B1 solution for 2 h. Then the slides were incubated with alka-
line phosphatase (AP)-conjugated anti-DIG antibodies (1 :
3000; Roche, Hertfordshire, UK) in 2.5% goat serum/B1 sol-
ution at 4°C overnight. On the third day, the slides were
washed in B1 Buffer and B3 Buffer (100 mM Tris–HCl (pH
9.5); 100 mM NaCl, 50 mM MgCl2 in autoclaved water) and
then incubated with 500 µl of AP substrate containing
4.5 µl ml−1 of nitro-blue tetrazolium chloride (NBT; Amresco,
Solon, USA) stock solution (75 mg ml−1 in 70% dimethylfor-
mamide) and 3.5 µl ml−1 of 5-bromo-4-chloro-30-
indolyphosphate p-toluidine (BCIP; Panreac AppliChem,
Darmstadt, Germany) stock solution (50 mg ml−1 in 70%
dimethylformamide) in dark humidified chambers. When
strong staining was observed, the slides were washed in auto-
claved water, dried on a hot plate, briefly washed in 100%
ethanol (2 × 10 s) and then cleared in Histo-Clear (National
Diagnostics, Nottingham, UK). Lastly, the slides were
mounted with a coverslip using HistoMount (National Diag-
nostics, Nottingham, UK). Images of stained sections were
captured using a QIClich CCD Colour Camera (Qimaging,
Birmingham, UK) linked to a DMRAI light microscope
(Leica Microsystems, Milton Keynes, UK) and Volocity
v. 6.3.1 image analysis software (Perkin-Elmer, Boston,
USA) running on an iMac computer (27 inch with OS Yose-
mite, v. 10.10).
royalsocietypublishing.org/journal/rsob
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52.9. Production and characterization of antibodies to
ArSS2
To enable generation of rabbit antisera to ArSS2, synthetic
ArSS2 (RAKNARCMADFWKGRGLVDC, with a disulfide
bridge between the cysteines; custom synthesized by Peptide
Protein Research Ltd, Fareham, UK) was conjugated to the
carrier protein porcine thyroglobulin (Sigma-Aldrich, Gilling-
ham, UK) using 5% glutaraldehyde (v/v) in phosphate buffer
(PB, 0.1 M sodium phosphate dibasic and 0.1 M sodium
phosphate monobasic, pH 7.2) as a coupling reagent. The
coupling reaction products were dialysed in PBS at 4°C for
approximately 48 h to remove low molecular mass com-
ponents and then the purified conjugate was aliquoted and
stored at −20°C. Rabbit immunization and serum collection
was performed by Charles River Labs (Margate, UK).
On day 0, pre-immune serum was collected and the first
immunization was administered. Booster immunizations
were administered on days 28, 42 and 56. Antiserum samples
were collected on days 37 and 51 and a final bleed was col-
lected on day 70. To assess production of antibodies during
the immunization protocol and following collection of a term-
inal bleed, enzyme-linked immunosorbent assays (ELISA)
were carried out to test antisera for the presence of antibodies
to ArSS2. One hundred microlitres of a 1 µM solution of anti-
gen peptide was added to each well of a PVC microtitre plate
(Starlab, Milton Keynes, UK) overnight at 4°C. After washing
with PBS, 200 µl 5% normal goat serum (Sigma-Aldrich,
Gillingham, UK) was added to each well at room temperature
for 2 h to block non-specific binding sites. Then after washing
with PBST, varying dilutions of antiserum or pre-immune
serum (10−1 to 10−6 diluted in 5% goat serum/PBS) were
added to each well. After overnight incubation at 4°C, the
antiserum solutions were washed away and each well was
incubated with alkaline phosphatase (AP)-labelled goat
anti-rabbit IgG secondary antibodies (Thermo Fisher Scienti-
fic, Oxford, UK; diluted 1 : 3000 in 5% goat serum/PBS) for
3 h at room temperature. Then after washing with PBST the
p-nitrophenylphosphate alkaline phosphatase substrate
(Vector Laboratories, Peterborough, UK) was added to each
well for a 20 min incubation at room temperature. Lastly,
absorbance at 415 nm was measured using a FLUOstar
Omega plate reader (BMG LABTECH, Ortenberg, Germany)
and then the mean absorbance values were calculated and
plotted using Prism 6.
2.10. Localization of ArSS2 in A. rubens using
immunohistochemistry
Small or medium-sized adult specimens of A. rubens were
fixed in Bouin’s solution (75% saturated picric acid in sea-
water, 25% formalin, 5% acetic acid) for at least 2 days at
4°C and then dissected to separate the arms and central
disc. These body parts were then decalcified in 1% ascorbic
acid/0.15 M sodium chloride solution at 4°C for at least one
week. After dehydration through an ethanol series, each
arm or central disc was embedded in paraffin and then 10
μm sections were cut using a microtome (RM 2145, Leica
Microsystems [UK], Milton Keynes, UK) and mounted on
chrome alum/gelatin-coated microscope slides. The slides
were incubated with xylene (3 × 10 min) to remove the paraf-
fin and then immersed in 100% ethanol twice. 0.3% hydrogenperoxide (VWR) in methanol was used to quench endogen-
ous peroxidase activity for 30 min and then an ethanol
series (90, 70, 50%) was used to rehydrate the tissue sections.
Slides were washed in distilled water and blocked in 5% goat
serum (Sigma-Aldrich, Gillingham, UK) made up in PBST for
2 h at room temperature. Finally, the slides were incubated at
4°C overnight with primary rabbit antiserum to ArSS2
(diluted 1 : 5000 in 5% goat serum/PBST). On the second
day, slides were washed with PBST and incubated for 3 h
with secondary antibodies (goat anti-rabbit horseradish
peroxidase conjugated immunoglobulins (Jackson ImmunoR-
esearch via Stratech Scientific, Newmarket, Suffolk, UK))
diluted 1 : 3000 in 2% goat serum/PBST. Immunostaining
was produced using a staining solution comprising 0.05%
diaminobenzidine (VWR Chemicals, Lutterworth, UK),
0.05% nickel chloride, 0.015% hydrogen peroxide diluted in
PBS. Distilled water was used to wash slides when the stain-
ing was observed. Following dehydration through washes
in autoclaved distilled water, ethanol (50, 70, 90, 100%)
and xylene, slides were mounted with coverslips using
DPX (Thermo Fisher Scientific, Oxford, UK) as a mounting
medium. To assess the specificity of immunostaining, anti-
serum pre-absorption was performed by incubating the
antiserum (diluted to 1 : 500 in PBS) with the ArSS2 antigen
peptide (20 µM) on a rocking shaker at room temperature
for 2 h. Then the pre-absorbed antiserum was diluted
10-fold to 1 : 5000 in 5% goat serum/PBST and tested on star-
fish sections, as described above. Images of stained sections
were captured as described in §2.8.
2.11. Analysis of the in vitro pharmacological effects of
ArSS2 on tube foot, apical muscle and cardiac
stomach preparations from A. rubens
Synthetic ArSS2 (RAKNARCMADFWKGRGLVDC, with a
disulfide bridge between the cysteine residues) was custom
synthesized (Peptide Protein Research Ltd, Fareham, UK) to
enable testing of its pharmacological effects on in vitro prep-
arations of organs/muscles from A. rubens. ArSS2 was tested
for its in vitro effects on the contractility of tube foot, apical
muscle and cardiac stomach preparations from at least six
different specimens of A. rubens. Individual tube foot prep-
arations were dissected from starfish arms with their
corresponding ampulla intact. Then cotton ligatures were
tied around the ambulacral body wall and the tube foot disc
and then the external epithelium of the tube foot was scraped
off using a blunt scalpel blade to facilitate penetration of pep-
tides when tested in vitro, as described previously [64,65].
Apical muscle preparations were dissected from the aboral
body wall with approximately 1 cm strips of apical muscle
tied at each end with cotton ligatures [64]. Cardiac stomach
preparations were dissected as described previously [53,65]
and then were tied at the aboral side of the cardiac stomach
and around the oesophagus with cotton ligatures. The dis-
sected preparations were tied to a fixed metal hook orally
and to a high-grade isotonic transducer (MLT0015; ADInstru-
ments Ltd; Oxford, UK) aborally, suspended in a 20 ml
aerated organ bath containing artificial seawater at approxi-
mately 11°C. The transducer was connected via a bridge
amplifier (FE221 Bridge Amp, ADInstruments Ltd, Oxford,
UK) to data acquisition hardware (PowerLab 2/36, ADInstru-
ments Ltd, Oxford, UK). Data collected from PowerLab were
royalsocietypublishing.org/journal/rsob
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6visualized as traces and analysed using LabChart (v. 8.0.7) soft-
ware installed on a laptop computer (Lenovo E540,Windows 7
Professional). Preliminary tests revealed that ArSS2 caused
relaxation of tube foot and cardiac stomach preparations but
had no effect on the contractile state of apical muscle prep-
arations. Therefore, the relaxing effects of ArSS2 on tube foot
and cardiac stomach preparations were investigated in more
detail.
To examine the effects of ArSS2 on tube foot and cardiac
stomach preparations, 10−6 M acetylcholine (ACh) or artificial
seawater (ASW) containing 30 mM added KCl was used to
induce contraction of these preparations, respectively. Once
a stable baseline contracted state was achieved, synthetic
ArSS2 was added into the organ bath to sequentially achieve
final concentrations in the range of 10−10 to 10−6 M. For these
experiments, the contracting effect of 10−6 M ACh or ASW
containing 30 mM added KCl was defined as 100% and the
relaxing effects of ArSS2 were then calculated as a percentage
reversal of the 100% contracted state.
To enable assessment of the magnitude of the relaxing
effect of ArSS2 on the cardiac stomach, experiments were per-
formed to compare the effect of ArSS2 with the effects of the
neuropeptides SALMFamide-2 (S2; SGPYSFNSGLTF-NH2)
and asterotocin (CLVQDCPEG-NH2 with a disulfide bridge
between the cysteines), both of which cause relaxation of
A. rubens cardiac stomach preparations in vitro [65–67]. Exper-
iments were performed where the effects of ArSS2, S2 and
asterotocin (at 10−7 and 10−6 M) on cardiac stomach prep-
arations (n = 6) were compared. For these experiments, the
effect of 10−7 or 10−6 M S2 was defined as 100% and the effect
of asterotocin or ArSS2 was calculated as a % of the effect of
S2. To determine if there were significant differences in magni-
tude of the relaxing effects of the three peptides on cardiac
stomach preparations, data were analysed statistically using a
two-tailed Student’s t-test in Prism 6.2.12. Analysis of the in vivo pharmacological of effects
of ArSS2 on A. rubens
When starfish (A. rubens) feed, the cardiac stomach is relaxed
and everted out of the mouth over the digestible soft tissues
of prey (e.g. mussels) [68,69]. Previous studies have revealed
that S2 and asterotocin induce relaxation of A. rubens cardiac
stomach preparations in vitro and also induce cardiac
stomach eversion when injected in vivo [66,67]. Therefore,
because ArSS2 causes relaxation of cardiac stomach prep-
arations in vitro, we investigated if ArSS2 also triggers
cardiac stomach eversion when injected in vivo. Firstly, 15
medium-sized starfish were starved for one week to normal-
ize their physiological status. A Hamilton 75N 50 µl syringe
(Sigma-Aldrich; Gillingham, UK) was used to inject 10 µl
1 mM ArSS2, or 10 µl 1 mM asterotocin (positive control) or
10 µl water (negative control) into the perivisceral coelom
of starfish. ArSS2 was tested on five individuals firstly and
then the next day, asterotocin was tested on the same batch
of five individuals. For another five individuals, asterotocin
was tested first and then ArSS2 was tested on the following
day. The remaining five individuals were injected with
water as a control. Thus, both ArSS2 and asterotocin were
tested on ten starfish. For each starfish, the test agent was
injected via two sites in the dorsal body wall of the arms
proximal to the junctions with the central disc region. Carewas taken to inject test agents into the perivisceral coelom
and not into the cardiac stomach. Starfish were placed indivi-
dually in a transparent Petri dish containing ASW and their
activity was video recorded for 10 min using a camera
(Canon EOS 700D) positioned underneath them so that their
oral surface could be viewed. Static images from video record-
ings were captured at 1 min intervals from the time of injection
and if stomach eversion occurred the two-dimensional area
of the everted cardiac stomach was measured using ImageJ
software (https://imagej.nih.gov/ij/) and then normalized
as a percentage of the area of the central disc region.3. Results
3.1. Sequencing of cDNAs encoding the A. rubens
neuropeptide precursors ArSSP1 and ArSSP2 and
mass spectrometric characterization of
neuropeptides (ArSS1 and ArSS2) derived from
these precursors in extracts of A. rubens radial
nerve cords
Cloning and sequencing of a cDNA encoding ArSSP1 (elec-
tronic supplementary material, figure S1) confirmed a
transcript sequence (contig 1107850) from A. rubens radial
nerve cord transcriptome data, which was previously referred
to as ArSSP (GenBank: KT601708) [48]. ArSSP1 is a 132-residue
protein comprising a predicted 24-residue N-terminal signal
peptide and the C-terminally located predicted SS-like peptide
ArSS1 (figure 1a). Analysis of A. rubens radial nerve cord
extracts using mass spectrometry enabled determination of
the mature structure of ArSS1, revealing that it is a 13-residue
peptide (KCIGRFQPFSMPC) that was identified as a 2+
charged precursormass 814.38m/z. This peptidewas identified
in samples of extracts that were subjected to reduction and
alkylation and accordingly, the two cysteine residues were
modified by carbamidomethylation, as seen in the MS/MS
mass spectrum by higher-energy collisional dissociation
(HCD) fragmentation (electronic supplementary material,
figure S3a). It is not possible to fragment cyclic peptides
that have a disulfide bridge using the standard MS/MS HCD
fragmentation and accordingly in samples of extracts where
reduction and alkylation was not performed, the ArSS1
peptidewas not identified. Collectively, these findings demon-
strate that the peptide ArSS1 has the amino acid sequence
KCIGRFQPFSMPC with a disulfide bridge between the
two cysteine residues and is present in A. rubens radial nerve
cord extracts.
Analysis of transcriptome sequence data from the brittle
star O. victoriae has revealed the presence of two transcripts
encoding SS-like neuropeptides [49], one of which is closely
related to ArSSP1. Submission of the secondO. victoriae precur-
sor sequence as a query for BLAST analysis of A. rubens radial
nerve cord transcriptome sequence data revealed the presence
of a contig (contig 1111056) encoding a closely related precur-
sor, which we have named ArSSP2 (GenBank: MN257487).
Cloning and sequencing of a cDNA encoding ArSSP2 con-
firmed the contig sequence (electronic supplementary
material, figure S2), revealing that it is a 102-residue protein,
comprising a predicted 22-residue N-terminal signal peptide
(a)
(b)
(c)
(d)
Figure 1. Sequences of the A. rubens neuropeptide precursors ArSSP1 and ArSSP2 and alignment of neuropeptides derived from these precursors (ArSS1 and ArSS2)
with related peptides from other taxa. (a) Amino acid sequence of ArSSP1, with the predicted signal peptide shown in blue, a dibasic cleavage site shown in green
and the neuropeptide ArSS1 shown in red. The underlined cysteine residues are predicted to form a disulfide bridge in the mature ArSS1 peptide. (b) Amino acid
sequence of ArSSP2, with the predicted signal peptide shown in blue, a dibasic cleavage site shown in green and the neuropeptide ArSS2 shown in red. The
underlined cysteine residues are predicted to form a disulfide bridge in the mature ArSS2 peptide. (c) Alignment of echinoderm SS1-type neuropeptides with
protostome ASTC-type peptides. Note that in addition to conserved cysteine residues, there is a conserved FXP motif (where X is variable). A GR motif is,
more specifically, a shared feature of the echinoderm peptides. (d ) Alignment of echinoderm SS2-type neuropeptides with chordate SS-type peptides. Note
that in addition to conserved cysteine residues, there is a conserved FWK/IWK motif. An aspartate (D) residue and two glycine (G) residues are, more specifically,
shared features of the echinoderm peptides. In (c,d ), the aligned amino acids are highlighted in black if the residue is present in at least 70% of the sequences or
highlighted in grey if conservative amino acid substitutions are present in at least 70% of the sequences. The position of a disulfide bridge between the two
conserved cysteine residues is shown above the alignments. Species and peptide names are highlighted in taxon-specific colours: yellow (Echinodermata),
green (Protostomes), pink (Cephalochordata), blue (Vertebrata). Species name abbreviations are as follows: Ajap, Apostichopus japonicus; Apla, Acanthaster
planci; Arub, Asterias rubens; Bflo, Branchiostoma floridae; Cele, Caenorhabditis elegans; Ctel, Capitella teleta; Dmel, Drosophila melanogaster, Hsap, Homo sapiens,
Lgig, Lottia gigantea; Ovic, Ophionotus victoriae; Spur, Strongylocentrotus purpuratus.
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7and the predicted C-terminally located SS-like peptide ArSS2
(RAKNARCMADFWKGRGLVDC) (figure 1b).
Analysis of A. rubens radial nerve cord extracts using
mass spectrometry enabled determination of the mature
structure of ArSS2, revealing that it is a 20-residue peptide
(RAKNARCMADFWKGRGLVDC) that was identified as a
4+ charged precursor mass 603.55 m/z. This peptide wasidentified in samples of extracts that were subjected to
reduction and alkylation and accordingly, the two cysteine
residues were modified by carbamidomethylation. However,
the MS/MS HCD fragmentation for this peptide was poor
(electronic supplementary material, figure S3b) and it was
not possible to confirm the full amino acid sequence. As
expected, this peptide was not identified in the samples
roya
8that were not subject to reduction and alkylation, providing
supporting evidence of the presence of a disulfide bridge as
discussed above for ArSS1. lsocietypublishing.org/journal/rsob
Open
Biol.10:2001723.2. Sequence alignment of ArSS1 and ArSS2 with
other SS/ASTC-type peptides
Comparison of the sequences of ArSS1 and ArSS2 with SS/
ASTC-type neuropeptides from other species revealed several
conserved features. All of the peptides contain a pair of
cysteine residues, which are predicted or known to form
an intramolecular disulfide bridge that confers a cyclic struc-
ture on the mature peptides (figure 1c,d). Furthermore, ArSS1
and other SS1-type peptides from echinoderms have a con-
served FXP motif (where X is variable) in common with
ASTC-type peptides from D. melanogaster and Caenorhabditis
elegans (figure 1c), while ArSS2 and SS2-type peptides from
other echinoderms have a conserved FWK/IWK motif in
common with SS-type peptides from chordates (figure 1d ).
Echinoderm-specific conservation of other residues in SS1-
type and SS2-type peptides can also been seen in figure 1c,
d, respectively. An alignment that combines the neuropeptide
sequences shown separately in figure 1c,d is presented in
electronic supplementary material, figure S4.3.3. Comparison of the structure of genes encoding
SS1- and SS2-type neuropeptides in echinoderms
and genes encoding SS/ASTC/UII-type
neuropeptides in other taxa
To further investigate relationships between echinoderm SS-
like peptides and SS/ASTC-type peptides in other taxa, we
compared the positions of introns in the protein-coding
regions of genes encoding these peptides (figure 2). The H.
sapiens SS and cortistatin (CST) genes both have a phase 0
intron interrupting exons encoding the N-terminal part of
the precursor proteins. This contrasts with the H. sapiens uro-
tensin II (UII) and Urotensin II-related peptide (URP) genes,
which both have a phase 1 intron interrupting exons encod-
ing the N-terminal part of the precursor proteins as well
as two or three introns interrupting exons encoding the
C-terminal part of the precursor proteins. Genes encoding
ASTC-type neuropeptides in protostome invertebrates (the
arthropod D. melanogaster, the nematode C. elegans, the mol-
lusc Mizuhopecten yessoensis) are similar to human SS/CST
genes in having a phase 0 intron interrupting exons encoding
the N-terminal part of the precursor proteins. However, the
D. melanogaster and C. elegans ASTC-type genes also have a
phase 2 intron interrupting exons encoding the C-terminal
part of the precursor proteins. Thus, the presence of a
phase 0 intron interrupting exons encoding the N-terminal
part of the precursor protein appears to be a conserved
characteristic of SS/ASTC-type precursor genes. It is note-
worthy, therefore, that both the SS1-type and SS2-type
precursor genes in the starfish A. planci and the sea urchin
S. purpuratus have a phase 0 intron interrupting exons encod-
ing the N-terminal part of the precursor protein. However,
the SS1-type neuropeptide genes also have a phase 1 intron
that interrupts exons encoding the C-terminal part of the pre-
cursor proteins. Collectively, these findings provide evidencethat the echinoderm SS1- and SS2-type precursor genes are
homologues of SS/ASTC-type genes in other taxa.
3.4. Identification of three transcripts encoding
orthologues of SS/ASTC-type receptors in A. rubens
To identify candidate receptors for ArSS1 and/or ArSS2 in
A. rubens, SS/ASTC-type receptor protein sequences were
submitted as queries for BLAST-based analysis of A. rubens
neural transcriptome sequence data. Contigs encoding five
proteins (contigs 1120385, 1108044, 1107700, 1119135 and
1121233) were identified as the top hits and homologues of
these proteins were also identified in other echinoderms,
including the starfish A. planci, the brittle star O. victoriae,
the sea urchin S. purpuratus and the sea cucumber A. japoni-
cus. To determine the relationship of these echinoderm
receptors with other bilaterian neuropeptide receptors,
phylogenetic analysis was carried out using the maximum-
likelihood method. In addition to bilaterian SS-type receptors
and protostome ASTC-type receptors, the following receptors
that are closely related to SS/ASTC-type receptors were also
included in this analysis—opioid-type receptors, MCH-type
receptors and urotensin II-type receptors. Galanin-type
receptors and kisspeptin-type receptors were included as out-
groups. This revealed that three of the five candidate
receptors identified in A. rubens (contigs 1120385, 1108044,
1107700) were positioned in a clade comprising chordate
SS-type receptors, chordate opioid-type receptors and proto-
stome ASTC-type receptors. However, the precise position of
the echinoderm receptors within this clade was dependent
on the extent of sequence trimming, with more trimming
placing the echinoderm receptors in a branch comprising
chordate SS-type and chordate opioid-type receptors
(figure 3) and with less trimming placing the echinoderm
receptors in a branch comprising protostome ASTC-type
receptors (electronic supplementary material, figure S5).
Therefore, these receptors were designated as SS/ASTC-
type receptors, but for simplicity were named ArSSR1
(contig 1120385), ArSSR2 (contig 1108044) and ArSSR3
(contig 1107700) (figure 3). The other two A. rubens receptors
(contigs 1119135 and 1121233) were positioned in a clade
comprising MCH-type receptors, and therefore these were
named ArMCHR1 and ArMCHR2, respectively (figure 3).
3.5. Pharmacological characterization of the
A.rubens SS/ASTC-type receptors ArSSR1,
ArSSR2 and ArSSR3
Having identified ArSSR1, ArSSR2 and ArSSR3 as candidate
receptors for ArSS1 and/or ArSS2, cDNAs encoding these pro-
teinswere cloned and sequenced so thatArSS1 andArSS2 could
be tested as ligands for these receptors. Cloning and sequencing
of cDNAs encoding ArSSR1, ArSSR2 and ArSSR3 confirmed
sequences obtained from A. rubens radial nerve cord tran-
scriptome sequence data (electronic supplementary material,
figures S6–S8) and these sequences have been deposited in
GenBank under accession numbers MN251831, MN251832
and MN251833, respectively. ArSSR1, ArSSR2 and ArSSR3
comprise 346, 418 and 341 amino acid residues, respectively,
and sequence analysis using Protter indicated the presence of
seven predicted transmembrane domains, as expected for
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Figure 2. Comparison of the exon/intron structure of genes encoding somatostatin/allatostatin-C-related precursors in echinoderms and other taxa. The figure shows
representations of the gene structures. The protein-coding exons are shown as rectangles and introns are shown as lines with intron length stated underneath. The
N-terminal signal peptide, the neuropeptide and monobasic or dibasic cleavage sites are shown in blue, red and green, respectively, with amino acid residue
positions shown underneath. Other regions of the precursor protein are shown in grey. The numbers above each precursor diagram show the phase of introns
with respect to the reading frame, with 0 representing an intron located between two consecutive codons, 1 representing an intron between the first and
second base of a codon and 2 representing an intron between the second and third base of a codon. Note that a shared characteristic of the echinoderm
SSP1-type and SSP2-type genes and SS/CST/ASTC-type genes in other taxa is the presence of a phase 0 intron interrupting the coding region for the N-terminal
part of the encoded proteins; this distinguishes these genes from UII/URP-type genes that have a phase 1 intron in an equivalent position. Species names are as
follows: Apla, Acanthaster planci; Cele, Caenorhabditis elegans; Dmel, Drosophila melanogaster; Hsap, Homo sapiens; Myes, Mizuhopecten yessoensis; Spur, Strongy-
locentrotus purpuratus. The neuropeptide precursor names are as follows: SS, somatostatin; CST, cortistatin; UII, urotensin II; URP, urotensin II-related peptide; ASTC,
allatostatin-C. Accession numbers for the sequences of the precursors shown in this figure are listed in electronic supplementary material, table S3.
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9G-protein-coupled receptors (electronic supplementary
material, figures S9–S11). The cloned receptor cDNAs were co-
transfected with Gα16 into CHO-cells stably expressing GFP-
aequorin so that synthetic ArSS1 and ArSS2 could be tested as
candidate ligands for these receptors at concentrations ranging
from 10−21 to 10−4 M. ArSS1 did not trigger luminescence in
cells expressing any of the three receptors, even at the highest
concentration tested. However, ArSS2 caused dose-dependent
luminescence in cells expressing ArSSR1, ArSSR2 and
ArSSR3, with half-maximal response concentrations (EC50) of
8.8 × 10−11 M, 4.2 × 10−12 M and 1.4 × 10−9 M, respectively
(figure 4a,c,e). At a concentration of 10−5 M, ArSS2 triggered
mean total luminescence responses in CHO-cells expressing
ArSSR1, ArSSR2 or ArSSR3 that were, respectively, 144 620
(figure 4b), 166 303 (figure 4d) and 46 575 (figure 4f ) times thebackground luminescence detected with the assay media used
to dissolve the peptides or with ArSS1. Thus, the efficacy of
ArSS2 as a ligand was higher for ArSSR1 and ArSSR2 than for
ArSSR3. Furthermore, statistical analysis of the data from
these experiments showed that for all three receptors, the lumi-
nescence in cells exposed toArSS2was significantly higher than
the luminescence in cells exposed to ArSS1 or BSA media (con-
trol). Neither ArSS1 nor ArSS2 elicited responses when tested
on CHO-K1 cells transfected with an empty vector (electronic
supplementary material, figure S12). Thus, these experiments
demonstrated that ArSS2, but not ArSS1, acts as a ligand for
theA. rubens receptorsArSSR1, ArSSR2 andArSSR3. Therefore,
we proceeded to investigate the physiological roles of ArSS2 in
A. rubens by analysing its expression and pharmacological
actions, as described below.
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Figure 3. Phylogenetic analysis identifies three A. rubens receptor proteins as somatostatin/allatostatin-C-type receptors. The tree generated using the maximum-
likelihood method (1000 bootstrap replicates, LG + F + I + G4 substitution model) comprises three distinct receptor clades—SS/ASTC/opioid-type receptors, MCH-
type receptors and urotensin II-type receptors. Galanin-type receptors and kisspeptin-type receptors were included here as outgroups to root the tree. The three A.
rubens receptor proteins characterized in this study (labelled with red arrows) are positioned in the clade containing SS/opioid/ASTC-type receptors, demonstrating
that they can be classified as SS/ASTC-type receptors. The round dots represent bootstrap support and the different coloured backgrounds highlight different taxo-
nomic groups (see legend). The scale bar represents the average residue substitution per site. Receptor names shown in red indicate that cognate ligands for these
receptors have been identified experimentally. Species names are as follows: Acal, Aplysia californica; Ajap, Apostichopus japonicus; Amel, Apis mellifera; Apla,
Acanthaster planci; Arub, Asterias rubens; Bflo, Branchiostoma floridae; Cele, Caenorhabditis elegans; Cgig, Crassostrea gigas; Ctel, Capitella teleta; Dmel, Drosophila
melanogaster; Dpul, Daphnia pulex; Hrob, Helobdella robusta; Hsap, Homo sapiens; Lgig, Lottia gigantea; Ovic, Ophionotus victoriae; Pdum, Platynereis dumerilii; Pmar,
Petromyzon marinus; Skow, Saccoglossus kowalevskii; Spur, Strongylocentrotus purpuratus; Tcas, Tribolium castaneum. Accession numbers of receptor sequences and
associated references used to generate this figure are listed in electronic supplementary material, table S4.
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103.6. Localization of ArSSP2 transcripts in A. rubens
using mRNA in situ hybridization
Analysis of the expression of ArSSP2 transcripts in A. rubens
using mRNA in situ hybridization revealed that ArSSP2 is
widely expressed, with ArSSP2-expressing cells detected in
the central nervous system (figure 5), digestive system
(figure 6), tube feet and body wall (figure 7).3.6.1. Central nervous system
The central nervous system of A. rubens comprises radial
nerve cords that are located on the underside of the five
arms and a circumoral nerve ring in the central disc region.The radial nerve cords and circumoral nerve ring comprise
two distinct regions—the ectoneural region that is thought
to largely contain sensory neurons and interneurons, and
the hyponeural region that contains only motor neurons.
Marginal nerves run parallel with the radial nerve cords,
lateral to the outer row of tube feet on each side of the
arm [70–72].
Transverse sections of radial nerve cords revealed that
ArSSP2 is expressed in both the ectoneural and hyponeural
regions. In the ectoneural region, there are stained cells scat-
tered throughout the subcuticular epithelial layer, but with
bilaterally symmetrical clusters of strongly stained cells
being most prominent close to the junction with adjacent
tube feet (figure 5a,b). In the hyponeural region, a few stained
cells can be observed in transverse sections (figure 5a,b).
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Figure 4. ArSS2, but not ArSS1, acts as a ligand for three A. rubens SS/ASTC-type receptors, ArSSR1, ArSSR2 and ArSSR3. The graphs show that ArSS2 causes dose-
dependent activation of ArSSR1 (a), ArSSR2 (c) and ArSSR3 (e) expressed with Gα16 in CHO-K1 cells stably expressing a calcium-sensitive bioluminescent GFP-
aequorin fusion protein G5A. Luminescence is expressed as a percentage of the maximal response observed in each experiment (a,c,e) and the ArSS2 mean
(±s.e.m.) EC50 values for each receptor are shown in red lettering. ArSS1 has no effect when tested over the same concentration range as ArSS2, demonstrating
the specificity of the activation of ArSSR1–3 by ArSS2 (a,c,e). Each point represents mean values (±s.e.m.) from at least three independent experiments, with three
repeats per experiment. (b,d,f ) Comparison of the total bioluminescence responses of ArSSR1 (b), ArSSR2 (d ) and ArSSR3 ( f ) expressing cells when exposed to ArSS2
and ArSS1 at a concentration of 10−5 M for 30 s. Cells exposed to BSA media were used as a control group. The mean luminescence responses to 10−5 M ArSS2 are
144 620 (b), 166 303 (d ) and 46 575 ( f ), respectively, showing that ArSS2 has higher efficacy as ligand for ArSSR1 and ArSSR2 than for ArSSR3. Analysis of the data
in (b,d,f ) by one-way ANOVA with Bonferroni’s multiple comparisons post hoc test revealed that luminescence in cells exposed to 10−5 M ArSS2 is significantly higher
(****p < 0.0001, **p < 0.01) than in cells exposed to 10−5 M ArSS1 or BSA media (control). Luminescence is not significantly different between receptor-expressing
cells exposed to 10−5 M ArSS1 and receptor-expressing cells exposed to BSA media.
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11The absence of stained cells in sections incubated with
sense probes confirmed the specificity of staining observed
with antisense probes (figure 5a inset). Anatomically, thecircumoral nerve ring corresponds to one half of the
V-shaped radial nerve cord and the pattern of ArSSP2 tran-
script expression in the circumoral nerve ring was generally
(a)
(c)
(e) (f) (g)
(d)
(b)
Figure 5. Localization of ArSSP2 mRNA in the nervous system of A. rubens using in situ hybridization. (a) Transverse section of a radial nerve cord incubated with
antisense probes showing stained cells (ArSSP2-expressing cells) in both the hyponeural (arrow) and ectoneural (arrowheads) regions. The inset shows the absence
of staining in a transverse section of radial nerve cord incubated with sense probes, demonstrating that staining observed with antisense probes can be attributed to
the detection of ArSSP2 transcripts. (b) Higher magnification image of the boxed region in (a), showing stained cells in the hyponeural region (arrows) and in the
subcuticular epithelial layer of the ectoneural region (arrowheads). (c) Transverse section of the central disc region showing stained cells in the hyponeural and
ectoneural regions of the circumoral nerve ring; stained cells can also be seen in an adjacent peri-oral tube foot. (d ) Higher magnification image of the boxed region
in (c), showing stained cells in the hyponeural region (arrow) and the subcuticular epithelial layer of the ectoneural region (arrowheads). (e) Longitudinal para-
sagittal section of a radial nerve cord showing stained cells in both the hyponeural (arrow) and ectoneural (arrowhead) regions. Note that in the hyponeural region,
the stained cells are clustered on either side of the transverse hemal strand. ( f ) Higher magnification image of the boxed region in (e), showing stained cells in the
hyponeural region (arrows) and the subcuticular epithelial layer of the ectoneural region (arrowheads). (g) Stained cells in the body wall external epithelium
proximal to the marginal nerve and in an adjacent tube foot (see also figure 7). CONR, circumoral nerve ring; Ec, ectoneural region; Hy, hyponeural region;
MN, marginal nerve; RHS, radial hemal strand; RNC, radial nerve cord; TF, tube foot; THS, transverse hemal strand. Scale bars: 18 µm in ( f ); 30 µm in (b,d,
g); 60 µm in (a), (a) inset, (c,e).
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12consistent with that in the radial nerve cords. In the ecto-
neural region of the circumoral nerve ring, there are two
distinct bands of strongly stained cells located close to the
junction with the neighbouring tube foot and another band
of stained cells close to the junction with the peristomial
membrane (figure 5c,d ). In the hyponeural region of the cir-
cumoral nerve ring, only a few stained cells can be seen
(figure 5c,d ). Longitudinal sections of radial nerve cords
revealed stained cells are distributed along the length of ecto-
neural subcuticular epithelium, whereas in the hyponeural
region, there is segmental clustering of stained cells proximal
to the transverse hemal strand (figure 5e,f ). ArSSP2-
expressing cells are also present in the epithelium overlying
the marginal nerves (figure 5g).3.6.2. Digestive system
In A. rubens and other starfish, the mouth is located on the
underside of the central disc and is surrounded by a contractile
peristomial membrane, which is continuous with a short tubu-
lar oesophagus. Aboral to the oesophagus is the cardiac
stomach, which is everted through the mouth during feeding.
Aboral to the cardiac stomach is the smaller pyloric stomach,
which is linked via a short rectum to the anus located on the
aboral surface of the central disc and linked by pyloric ducts
to paired pyloric caeca located in each arm [68,73]. ArSSP2
expression was revealed in several regions of the digestive
system. In the peristomial membrane, stained cells were
observed in the external epithelium in continuity with the
(a)
(c)
(f)
(g)
(b)
(d)
(e)
(h) (i)
Figure 6. Localization of ArSSP2 mRNA in the digestive system of A. rubens using in situ hybridization. (a) Transverse section through the central disc region showing
stained cells in the peristomial membrane and in the circumoral nerve ring that surrounds the peristomial membrane. (b) Higher magnification image of the boxed region
shown in (a), showing stained cells (arrowheads) in the external epithelium of the peristomial membrane. (c) Transverse section through the central disc region showing
sparsely distributed stained cells in the cardiac stomach and pyloric stomach. (d ) Higher magnification image of the boxed region of the pyloric stomach in (c), showing
elongate shaped stained cells (arrowhead) in the mucosal layer and roundish shaped stained cells (arrow) close to the position of basi-epithelial nerve plexus. (e) Higher
magnification image of the boxed region of the cardiac stomach in (c), showing elongate shaped stained cells (arrowhead) in the mucosal layer and roundish shaped
stained cells (arrows) close to the position of the basi-epithelial nerve plexus. ( f ) Transverse section of a pyloric duct showing elongate shaped stained cells (arrowhead)
and roundish shaped stained cells (arrow) located on both the aboral (upper) and oral (lower) sides. (g) Higher magnification image of the boxed region of ( f ) showing
elongate shaped stained cells (arrowheads) in the mucosal layer. (h) Transverse section of an arm showing stained cells in a pyloric caecum. (i) Higher magnification image
of the boxed region in (h), showing elongate shaped stained cells (arrowhead) in the mucosal layer and roundish shaped stained cells (arrow) close to the position of basi-
epithelial nerve plexus. BNP, basi-epithelial nerve plexus; CONR, circumoral nerve ring; CS, cardiac stomach; Lu, lumen; Mu, mucosal layer; PC, pyloric caecum; PM, peri-
stomial membrane; PS, pyloric stomach. Scale bars: 18 µm in (b); 30 µm in (a,e); 36 µm in (g); 60 µm in (d,f,i); 120 µm in (c,h).
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13ectoneural region of the circumoral nerve ring (figure 6a,b). In
the cardiac stomach andpyloric stomach, sparse populations of
stained cells were observed (figure 6c), with elongate shaped
cells located in the mucosal layer and roundish shaped cells
located close to the position of the basi-epithelial nerve
plexus (figure 6d,e). Stained cellswere also detected in the pylo-
ric duct and pyloric caeca, located in the mucosal layer andbasi-epithelial nerve plexus on both the oral and aboral sides
of these parts of the digestive system (figure 6f–i).
3.6.3. Body wall and tube feet
The body wall of A. rubens comprises an outer epithelium
layer, a dermal layer and a coelomic epithelium layer. The
(a) (c)
(d) (e)
(f) (g)
(b)
Figure 7. Localization of ArSSP2 mRNA in the tube feet and body wall of A. rubens using in situ hybridization. (a) Longitudinal section of a tube foot showing
staining in both the stem and disc regions. (b) Higher magnification image of the stem region of (a), showing stained cells (arrowheads) in a subepithelial position.
(c) Higher magnification image of the boxed region of (a) at the junction between the stem and the disc, showing a cluster of stained cells around the basal nerve
ring. (d ) Transverse section of the aboral body wall of an arm showing stained cells in the circular muscle layer proximal to the apical muscle. (e) Higher mag-
nification image of the boxed region of (d ), showing stained cells (arrowheads) in the circular muscle layer, which is located beneath the coelomic epithelium. ( f )
Transverse section of an arm showing staining in the external epithelium of the body wall. (g) Higher magnification image of the boxed region of ( f ), showing
stained cells (arrowheads) in the external epithelium of the body wall. AM, apical muscle; BNR, basal nerve ring; CE, coelomic epithelium; CT, collagenous tissue; Di,
disc; Ep, epithelium; ML, muscle layer; SNP, subepithelial nerve plexus; St, stem. Scale bars: 32 µm in (b); 60 µm in (c,e,f,g); 120 µm in (a,d ).
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14dermal layer comprises calcite ossicles that are linked by
muscles within collagenous tissue. Circularly and longitudin-
ally orientated muscle layers are beneath the coelomic
epithelium layer. The longitudinally orientated muscle layer
is thickened in the midline of the aboral body wall of each
arm to form the apical muscle. The external aboral surface
of the body wall has many appendages, including pedicellar-
iae, spines and papulae. The oral surface of the body wall
comprises ambulacral ossicles, adambulacral ossicles and
four rows of tube feet that are linked to ampullae located
internally [74]. Stained cells expressing ArSSP2 were revealed
in tube feet in a subepithelial position along the length of the
stem (figure 7a,b), in close association with the basal nerve
ring (figure 7c) and in the disc region (figure 7a). Stained
cells expressing ArSSP2 were also revealed in the circular
muscle layer beneath the coelomic epithelium (figure 7d,e)
and in the external epithelium of the body wall (figure 7f,g).3.7. Localization of ArSS2 expression in A. rubens using
immunohistochemistry
Enzyme-linked immunosorbent assays (ELISA) were used to
test for the presence of antibodies to ArSS2 in serum from a
rabbit that had been immunized with a conjugate ofthyroglobulin and ArSS2. Antibodies to ArSS2 were not
detected in pre-immune serum, as expected. Analysis of
serum from the final bleed revealed that antibodies to
ArSS2 could be detected with serum dilutions as low as
10−4 (electronic supplementary material, figure S13). The
rabbit antiserum to ArSS2 has been assigned the RRID:
AB_2847910.
Informed by these results, the ArSS2 antiserum was used
at a dilution of 1 : 5000 for immunohistochemical analysis of
ArSS2 expression in A. rubens. ArSS2-immunoreactivity (ir)
was revealed in the central nervous system (figure 8), diges-
tive system (figure 9), tube feet and body wall (figure 10),
with the distribution of immunostained cells consistent
with distribution of cells expressing ArSSP2 transcripts
(figures 5–7). No staining was observed in sections incubated
with antiserum pre-absorbed with the ArSS2 peptide, con-
firming the specificity of immunostaining observed with the
antiserum (figure 8a inset).3.7.1. Nervous system
ArSS2-ir was observed in the radial nerve cords (figure 8a,b,
d–f ), marginal nerves (figure 8c) and circumoral nerve ring
(figure 8g–i) of A. rubens, with the location of stained cells
consistent with the distribution of ArSSP2 transcripts
(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
Figure 8. Localization of ArSS2 in the nervous system of A. rubens using immunohistochemistry. (a) Transverse section of the radial nerve cord showing ArSS2-
immunoreactivity (immunostaining) in the hyponeural (arrows) and ectoneural (arrowheads) regions. In the ectoneural region, immunostained cells are located in
the subcuticular epithelial layer, largely concentrated laterally, and immunostained fibres are present in the neuropile. The inset shows an absence of immunostain-
ing in sections of radial nerve cord incubated with ArSS2 antiserum pre-absorbed with the ArSS2 peptide antigen, demonstrating the specificity of immunostaining
observed in sections incubated with the ArSS2 antiserum. (b) Higher magnification image of the boxed region of (a), showing immunostained bipolar shaped cells in
the subcuticular epithelium of the ectoneural region (arrowheads), immunostained roundish shaped monopolar cells in the hyponeural region (arrows) and immu-
nostained fibres in the neuropile (asterisk). (c) Immunostaining in the marginal nerve (arrowhead) and immunostained fibres in the lateral motor nerve (arrows).
(d ) Longitudinal parasagittal section of a radial nerve cord showing immunostained cells in the hyponeural region (arrows) and ectoneural region (arrowheads).
In the hyponeural region, immunostained cells are largely clustered near to the transverse hemal strand, whereas in the ectoneural region, immunostained cells are
distributed evenly along the length of the radial nerve cord. Immunostained fibres are present throughout the ectoneural neuropile (asterisk). (e) Higher magni-
fication image of the boxed ectoneural region of (d ), showing immunostained bipolar shaped cells in the subcuticular epithelium (arrowheads) and immunostained
fibres in the ectoneural neuropile (asterisk). ( f ) Higher magnification image of the boxed hyponeural region of panel (d ), showing immunostained roundish mono-
polar cells. (g) Transverse section of the circumoral nerve ring showing immunostained cells in the hyponeural and ectoneural regions. Immunostained fibres are
present in the ectoneural neuropile (asterisk) and are continuous with immunostained fibres in the basi-epithelial plexus of the adjacent peristomial membrane.
(h) Higher magnification image of the boxed ectoneural region of (g), showing immunostained bipolar shaped cells (arrowheads) in the subcuticular epithelium.
(i) Higher magnification image of the boxed hyponeural region of (g), showing immunostained roundish monopolar cells (arrows) and immunostained fibres in the
adjacent ectoneural neuropile (asterisk). CONR, circumoral nerve ring; Ec, ectoneural region; Hy, hyponeural region; MN, marginal nerve; PM, peristomial membrane;
THS, transverse hemal strand; RHS, radial hemal strand; RNC: radial nerve cord; TF, tube foot. Scale bars: 4.8 µm in (h); 8 µm in (b,e,f,i); 32 µm in (a), (a) inset,
(d,g); 36 µm in (c).
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15revealed using mRNA in situ hybridization. Thus, in the radial
nerve cords, bipolar shaped stained cells can be seen in the sub-
cuticular epithelium of the ectoneural region (figure 8a,b,d,e)
and roundish monopolar cells can be seen in the hyponeural
region (figure 8a,b,d,f ). In transverse sections, immunostained
cells can be seen predominantly located in the lateral regions
of the radial nerve cord and sparsely distributed in the apical
region (figure 8a). Furthermore, immunostained fibres are pre-
sent in the neuropile of the ectoneural region (figure 8a,b,d ).
However, the intensity of immunostaining in transverse sec-
tions of the ectoneural neuropile is not homogeneous, with
some regions more densely stained than others (figure 8a).
In longitudinal parasagittal sections of the radial nerve cord,
it can be seen that stained cells in the ectoneural subcuticular
epithelium are distributed along the length of the nerve cord
without apparent clustering (figure 8d ). Likewise, the intensity
of immunostaining in the ectoneural neuropile appears to be
quite homogeneous along the length of the nerve cord
(figure 8d). This contrasts with the hyponeural region, where
distinct clusters of stained cells can be seen in longitudinal sec-
tions, most notably in close proximity to the transverse hemal
strand (figure 8d ). The pattern of immunostaining observed in
transverse sections of the circumoral nerve ring is consistent
with that observed in transverse sections of the radial nervecords, with stained cells in both the ectoneural and hyponeural
regions and some variation in the density of immunostained
fibres in the ectoneural neuropile (figure 8g–i). Immunostain-
ing was also observed in the marginal nerves and internal to
the marginal nerves immunostained fibres could be observed
in the lateral motor nerves (figure 8c).
3.7.2. Digestive system
Immunostainingwas revealed in several regions of the digestive
system in A. rubens, including the peristomial membrane
(figure 9a,b), cardiac stomach (figure 9c,e), pyloric stomach
(figure 9c,d), pyloric ducts (figure 9f,g) and pyloric caeca
(figure 9h,i). The majority of this immunostaining is localized
in the basi-epithelial nerve plexus of each region of the digestive
system. In the peristomial membrane, the immunostained basi-
epithelial nerve plexus is contiguous with the immunostained
ectoneural region of the circumoral nerve ring (figure 9a,b).
Immunostained cells are distributed sparsely in the external epi-
thelial layer of the peristomial membrane (figure 9a,b). In the
cardiac stomach, elongate shaped stained cells can be seen in
themucosal layer adjacent to the immunostained basi-epithelial
nerve plexus (figure 9e). Transverse sections of the pyloric duct
show that immunostaining is present throughout the
(a) (b)
(d)(c)
(f)
(h)
(e)
(g)
(i)
Figure 9. Localization of ArSS2 in the digestive system of A. rubens using immunohistochemistry. (a) Transverse section through the central disc showing ArSS2-
immunoreactivity (immunostaining) in the peristomial membrane and the circumoral nerve ring. Immunostained cells are distributed sparsely in the external epi-
thelial layer of the peristomial membrane and stained fibres are present in the underlying basi-epithelial nerve plexus and contiguous with the immunostained
ectoneural region of the circumoral nerve ring. (b) Higher magnification image of the boxed region of peristomial membrane of (a), showing immunostained cells
(arrowheads) in the external epithelial layer and immunostained fibres in the underlying basi-epithelial nerve plexus (arrow). (c) Transverse section through the
central disc region showing immunostained fibres in the cardiac stomach and pyloric stomach regions. (d ) Higher magnification image of the boxed region of the
pyloric stomach in (c), showing immunostained fibres in the basi-epithelial nerve plexus. (e) Higher magnification image of the bottom boxed region of the cardiac
stomach in (c), showing one bipolar shaped cell (arrowhead) in the mucosa layer and immunostained fibres in the basi-epithelial nerve plexus. ( f ) Transverse section
of a pyloric duct showing immunostained fibres located on the aboral and oral sides, but with immunostaining more prominent on the oral side. (g) Higher
magnification image of the boxed region of ( f ), showing immunostained fibres in the basi-epithelial nerve plexus on the oral side of the pyloric duct. (h) Transverse
section of a starfish arm showing immunostaining present in a pyloric caecum, with region-specific variation in the intensity of immunostained fibres in the basi-
epithelial nerve plexus. (i) Higher magnification image of the boxed region of the pyloric caecum in (h), showing immunostained cells (arrow) in the mucosal layer
and immunostained fibres in the basi-epithelial nerve plexus. BNP, basi-epithelial nerve plexus; CONR, circumoral nerve ring; CS, cardiac stomach; CT, collagenous
tissue; Lu, lumen; Mu, mucosa; PC, pyloric caecum; PD, pyloric duct; PM, peristomial membrane; PS, pyloric stomach. Scale bars: 12 µm in (b,d,eg); 24 µm in (i);
48 µm in (a), (h); 60 µm in ( f ); 120 µm in (c).
royalsocietypublishing.org/journal/rsob
Open
Biol.10:200172
16
(a) (b)
(d)
(c)
(e)
(g) (h)
(f)
(i)
Figure 10. Localization of ArSS2 in the tube feet, body wall and terminal tentacle of A. rubens using immunohistochemistry. (a) Longitudinal section of a tube foot
showing ArSS2-immunoreactivity (immunostaining) in the subepithelial nerve plexus along the length of the stem and extending into the basal nerve ring of the disc
region. (b) Higher magnification image of the lower boxed region of (a), showing immunostaining in the basal nerve ring of the disc region. (c) Higher magnification image
of the upper boxed region of (a), showing immunostaining in the subepithelial nerve plexus along the length of the stem. (d ) Transverse section of an arm tip, showing
immunostaining in the terminal tentacle, lateral lappet, optic cushion and the surrounding body wall epithelium (arrow). (e) High magnification image of the lower boxed
region of (d ), showing immunostained bipolar shaped cells in the folded external epithelial layer of the terminal tentacle (arrowheads). ( f ) High magnification image of
the upper boxed region of (d ), showing immunostained fibres in the basi-epithelial nerve plexus (arrow) of the body wall epithelium adjacent to the terminal tentacle and
immunostained cells in a lateral lappet (arrowheads). (g) Transverse section of an arm showing immunostaining in a pedicellaria and the nerve plexus beneath the
external epithelium of the body wall. (h) High magnification image of the upper boxed region of (g), showing immunostained fibres between muscles of a pedicellaria.
(i) High magnification image of the lower boxed region of (g), showing immunostained fibres in the nerve plexus beneath the external epithelium of the body wall. BNR,
basal nerve ring; BW, body wall; CT, collagenous tissue; CuL, cuticular layer; Ep, epithelium; LL, lateral lappet; ML, muscle layer; OC, optic cushion; Pe, pedicellaria; SNP,
subepithelial nerve plexus; TT, terminal tentacle. Scale bars: 12 µm in (b,c,e); 24 µm in ( f,h,i); 60 µm in (d,g); 120 µm in (a).
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18basi-epithelial nerve plexus but the staining is most intense on
the oral (lower) side of the pyloric duct (figure 9f,g). Likewise,
regional variation in the intensity of immunostaining is
observed in the basi-epithelial nerve plexus of the pyloric
caeca (figure 9h,i).
3.7.3. Tube feet, terminal tentacle and body wall
In longitudinal sections of tube feet, immunostaining can be
seen in the subepithelial nerve plexus along the length of the
podium and extending into the basal nerve ring of the disc
region (figure 10a–c). Likewise, an extensive population of
immunostained cells and an associated nerve plexus were
revealed in the terminal tentacle and associated sensory
organs, which include the optic cushion and lateral lappets
(figure 10d–f ). In the optic cushion, immunostained bipolar
shaped cells were observed in the photoreceptor cell layer
(figure 10d ). Immunostaining was also observed in the
nerve plexus beneath the external epithelium of the body
wall and in nerve fibres innervating pedicellariae, which
are pincer-like appendages that remove debris and encrusting
material from the external body surface (figure 10g–i).
3.8. ArSS2 causes dose-dependent relaxation of tube foot
and cardiac stomach preparations from A. rubens
In vitro pharmacological tests revealed that ArSS2 causes relax-
ation of tube foot and cardiac stomach preparations from
A. rubens, but ArSS2 had no observable effects on the contracti-
lity of apical muscle preparations (data not shown). ArSS2
caused dose-dependent relaxation of tube foot preparations at
concentrations between 10−9 and 10−6 M.At the highest concen-
tration tested (10−6 M), ArSS2 caused 91%± 13% (n = 6) reversal
of ACh (10−6 M) induced tube foot contraction (figure 11a).
Likewise, ArSS2 caused dose-dependent relaxation of
cardiac stomach preparations at concentrations between 10−9
and 10−6 M. At the highest concentration tested (10−6 M),
ArSS2 caused 60 ± 18% (n = 10) reversal of KCl (30 mM)-
induced cardiac stomach contraction (figure 11b). Previous
studies have revealed that both the SALMFamide neuropeptide
S2 (SGPYSFNSGLTF-NH2) and the vasopressin/oxytocin-type
neuropeptide asterotocin (CLVQDCPEG-NH2) act as cardiac
stomach relaxants in A. rubens [64,67]. Therefore, to evaluate
the efficacy of ArSS2 as a cardiac stomach relaxant, we com-
pared its effect with the effects of S2 and asterotocin, testing
the peptides at concentrations of 10−7 and 10−6 M. At 10−7 M,
the mean magnitude of the relaxing action of ArSS2 was 1.5
times the effect of S2 but only 44% of the effect of asterotocin.
The mean magnitude of the relaxing action of asterotocin was
3.5 times the effect of S2 (figure 11c), consistent with findings
of a previous study [67]. At a concentration of 10−6 M, the
meanmagnitude of the relaxing action ofArSS2was not signifi-
cantly different to the effect S2 but was 50% of the effect of
asterotocin (figure 11d). Thus, ArSS2 acts as a muscle relaxant
in A. rubens but is less effective as a cardiac stomach relaxant
than asterotocin.
3.9. ArSS2 triggers partial cardiac stomach eversion in
A. rubens
Asterias rubens feeds by everting its cardiac stomach through
a narrow oral opening (mouth) and over the digestible partsof its prey, and for this to be accomplished, the cardiac
stomach must be in a relaxed state [68,69]. Neuropeptides
that cause cardiac stomach in vitro are therefore potential
mediators of cardiac stomach eversion in vivo. Previous
studies have revealed that injection of 100 µl 10−3M asteroto-
cin into the perivisceral coelom triggers complete eversion of
the cardiac stomach in A. rubens [67]. Therefore, here we
investigated if ArSS2 also triggers cardiac stomach eversion
in A. rubens. Our in vitro experiments (figure 11) revealed
that at a concentration 10−6 M, ArSS2 causes maximal relax-
ation of cardiac stomach preparations. The volume of the
pervisceral coelomic fluid in A. rubens is approximately
10 ml in medium-sized animals, and therefore we injected
10 µl 10−3 M ArSS2 into the perivisceral coelom of A. rubens
(n = 10) to achieve an estimated perivisceral concentration of
10−6 M in vivo. Starfish injected with 10 µl water were used
as the control group (n = 5) and starfish injected with 10 µl
10−3 M asterotocin (n = 10) were used as a positive control
group. Both ArSS2 and asterotocin triggered cardiac stomach
eversion in all of the animals injected with these peptides,
with eversion commencing at 1–2 min after injection
(figure 12a). The mean maximal eversion occurred approxi-
mately 4 min after injection with ArSS2 and approximately
9 min after injection with asterotocin. However, the magni-
tude of cardiac stomach eversion induced by ArSS2 was
much less than that induced by asterotocin, with the mean
maximal eversion induced by ArSS2 and asterotocin corre-
sponding to approximately 10% and 125% of the area of
the central disc region, respectively. Representative images
of starfish at 0, 5 and 10 min after injection with water,
ArSS2 and asterotocin are shown in figure 12b (i–iii), (iv–vi)
and (vii–ix), respectively.4. Discussion
SS-type neuropeptides in vertebrates and allatostatin-C
(ASTC)-type neuropeptides in protostome invertebrates
(e.g. the arthropod D. melanogaster) are members of a family
of structurally and evolutionarily related neuropeptides
that originated in a common ancestor of the Bilateria [22,75].
Functional characterization of SS-type and ASTC-type neuro-
peptides has revealed that they typically act as inhibitory
regulators of physiological processes in vertebrates and
arthropods, respectively [7,76]. However, little is known
about SS/ASTC-type neuropeptide signalling in other taxa.
Of particular interest from an evolutionary perspective are
deuterostome invertebrates, which occupy an ‘intermediate’
phylogenetic position with respect to vertebrates and
protostomes [45,47]. Accordingly, here we report the first
molecular and functional characterization of SS/ASTC-type
neuropeptide signalling in a deuterostome invertebrate—the
starfish A. rubens (phylum Echinodermata).
4.1. Molecular characterization of SS/ASTC-type
signalling in the starfish A. rubens
Analysis of A. rubens neural transcriptome sequence data
enabled identification of two transcripts encoding SS/
ASTC-type neuropeptide precursors (ArSSP1, ArSSP2), and
the sequences of these precursors were confirmed by cDNA
cloning and sequencing. Consistent with the characteristics
of SS/ASTC-type precursors in other taxa [24], ArSSP1 and
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Figure 11. ArSS2 causes relaxation of in vitro preparations of tube feet and cardiac stomach from A. rubens. (a) Graphs showing the dose-dependent relaxing effect
of ArSS2 on tube foot preparations at concentrations ranging from 10−10 to 10−6 M. The responses are expressed as the mean percentage reversal (±s.e.m.; n = 6)
of the contraction induced by 10−6 M acetylcholine (ACh). (b) Upper: representative recording showing that ArSS2 causes dose-dependent relaxation of a cardiac
stomach preparation that was pre-contracted with seawater containing 3 × 10−2 M added KCl. Lower: graph showing the dose-dependent relaxing effect of ArSS2
on cardiac stomach preparations at concentrations ranging from 10−10 to 10−6 M. The responses are expressed as the mean percentage reversal (±s.e.m.; n = 10) of
the contraction induced by 3 × 10−2 M KCl. (c) Representative recording of a cardiac stomach preparation that compares the relaxing effects of ArSS2, the SAL-
MFamide-type neuropeptide S2 and asterotocin (Ast) at a concentration of 10−7 M. As in (b), the cardiac stomach preparation was pre-contracted with KCl-
supplemented seawater prior to application of the neuropeptides. The graph below compares the effects of S2, ArSS2 and Ast on cardiac stomach preparations
at a concentration of 10−7 M, expressed as mean percentages (±s.e.m.; n = 6) with the relaxing effect of S2 defined as 100%. The relaxing effect of Ast is sig-
nificantly larger than the effect of S2 (two-tailed Student’s t-test; p = 0.0055; n = 6) and the effect of ArSS2 (two-tailed Student’s t-test; p = 0.0250; n = 6). The
relaxing effect of ArSS2 is significantly larger than the effect of S2 (two-tailed Student’s t-test; p = 0.0303; n = 6). (d ) Representative recording of a cardiac stomach
preparation that compares the relaxing effects of S2, ArSS2 and Ast at a concentration of 10−6 M. As in (c), the cardiac stomach preparation was pre-contracted with
KCl-supplemented seawater prior to application of the neuropeptides. The graph below compares the effects of S2, ArSS2 and Ast on cardiac stomach preparations at
a concentration of 10−6 M, expressed as mean percentages (±s.e.m.; n = 6) with the relaxing effect of S2 defined as 100%. The relaxing effect of Ast is significantly
larger than the effect S2 (two-tailed Student’s t-test; p = 0.0255; n = 6) and the effect of ArSS2 (two-tailed Student’s t-test; p = 0.0483; n = 6). There is not a
significant difference in the magnitude of the relaxing effects of ArSS2 and S2.
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19ArSSP2 each contain a single SS/ASTC-type neuropeptide
located in the C-terminal region of the protein. Analysis of
extracts of A. rubens radial nerve cords using mass spec-
trometry enabled investigation of the structure of the SS/
ASTC-type neuropeptides derived from ArSSP1 and
ArSSP2, which we refer to as ArSS1 and ArSS2, respectively.
The structure of ArSS1 was determined as a 13-residuepeptide (KCIGRFQPFSMPC) with a disulfide bridge between
the two cysteine residues. Partial structural data were
obtained for ArSS2 but a peptide with 4+ charged precursor
mass 603.55 m/z and two cysteines modified by carb-
amidomethylation was detected (electronic supplementary
material, figure S3b), consistent with the predicted structure
of ArSS2 (RAKNARCMADFWKGRGLVDC, with a disulfide
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Figure 12. In vivo injection of ArSS2 triggers cardiac stomach eversion in A. rubens. (a) Temporal dynamics of ArSS2 (red; 10 µl of 10−3 M) and asterotocin (Ast)
(black; 10 µl of 10−3 M) induced cardiac stomach eversion. The graph shows the mean area (±s.e.m.; n = 10) of the cardiac stomach everted expressed as a
percentage of the area of the central disc region at 1 min intervals over a 10 min period following injection of ArSS2 or Ast. (b) Photographs from video recordings
of the experiment in (a) showing representative control (water-injected) starfish (i–iii), ArSS2-injected starfish (iv–vi) and Ast-injected starfish (vii–ix) at 0, 5 and
10 min after injection. The cardiac stomach eversion area is labelled with a dashed line in (v,vi,viii,ix).
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20bridge between the two cysteine residues). Furthermore,
synthesis and testing of this peptide revealed that it acts
as a potent ligand for A. rubens SS/ASTC-type receptors, as
discussed below.
Orthologues of both ArSSP1 and ArSSP2 are present in
other echinoderms, including ophiuroids (brittle stars), echi-
noids (e.g. sea urchins) and holothurians (sea cucumbers)[48,49,77]. Furthermore, the predicted neuropeptides derived
from these precursor proteins share sequence similarity with
ArSS1 and ArSS2. A characteristic of the echinoderm SS-like
peptides and SS/ASTC-type neuropeptides in other taxa is a
pair of cysteine residues, which form a disulfide bridge in the
mature peptides. However, there is variability in the number
of residues between the cysteine residues (figure 1), with
royalsocietypublishing.org/journal/rsob
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SS2-type peptides having 12–15 residues, human SS/CST-
type peptides having 10 residues, an SS-type peptide in the
invertebrate chordate Branchiostoma floridae having 13 residues
and protostome ASTC-type peptides having 6 residues. Thus,
in this respect, the echinoderm SS-like peptides share more
similarity with chordate SS/CST-type peptides than with
protostome ASTC-type peptides. However, more specific
sequence comparisons revealed that echinoderm SS1-type
peptides have a core FXP motif (where X is variable) in
common with ASTC-type neuropeptides from D. melanogaster
andC. elegans, whereas the echinodermSS2-type peptides have
a core FWK/IWK motif in common with chordate SS-type
neuropeptides. This suggests that echinoderm SS1-type
peptides may be orthologues of protostome ASTC-type
neuropeptides and echinoderm SS2-type peptides may be
orthologues of chordate SS-type neuropeptides.
Previous studies have revealed that the presence, position
andphase of introns are evolutionarily conserved characteristics
of neuropeptide precursor genes that can provide evidence of
orthology [78]. Here, we found that, in common with SS/
ASTC-type genes in other taxa, echinoderm SS1-type and SS2-
type precursor genes have a phase 0 intron at a position that
interrupts the codingsequence for theN-terminalpart of thepre-
cursor proteins. Furthermore, echinoderm SS1-type precursor
genes have a second intron that interrupts the coding sequence
for the C-terminal half of the precursor proteins, which is also
a feature of the C. elegans and D. melanogaster ASTC genes
(figure 2). However, this could be a convergent characteristic
due to differences in the phase of the second intron. Thus,
analysis of gene structure provided additional evidence that
echinoderm SS1-type and SS2-type neuropeptides share a
common evolutionary origin with SS/ASTC-type neuropep-
tides in other taxa, but without providing definitive evidence
of a more specific orthology relationship with protostome
ASTC-type and chordate SS-type neuropeptides, respectively.
To further investigate relationships of echinoderm SS/
ASTC-type neuropeptides with SS/ASTC-type neuropeptides
in other taxa, we sought to identify receptors for the A. rubens
neuropeptides ArSS1 and ArSS2. Three A. rubens G-protein-
coupled receptors (ArSSR1, ArSSR2 and ArSSR3) that are
homologues of SS/ASTC-type receptors in other taxa were
identified. Furthermore, homologues of these receptors
were also identified in other echinoderms and phylogenetic
analysis revealed that the A. rubens and other echinoderm
receptors are positioned in a clade comprising chordate SS-
type receptors, chordate opioid receptors and protostome
ASTC-type receptors. Importantly, this clade is distinct from
clades comprising MCH-type receptors and UII-type recep-
tors. Therefore, ArSSR1–3 and related receptors in other
echinoderms can be classified as SS/ASTC-type receptors.
Pharmacological characterization of ArSSR1–3 revealed
that ArSS2 acts as a ligand for all three receptors, but the
efficacy and potency of ArSS2 as a ligand was higher for
ArSSR1 and ArSSR2 than for ArSSR3. Importantly, ArSS1
did not act as a ligand for any of the receptors. Thus,
ArSS2 and ArSSR1–3 in A. rubenswere identified here as mol-
ecular components of the first SS/ASTC-type neuropeptide
signalling system to be characterized pharmacologically in
an echinoderm. The identity of the receptor(s) for ArSS1
and SS1-type neuropeptides in other echinoderms remains
to be determined. It is noteworthy, however, that our analysis
of echinoderm genome sequence data has not identified anyadditional candidate SS/ASTC-type receptors; for example,
BLAST analysis of the genome sequence of the starfish
A. planci only identified genes encoding orthologues of the
three A. rubens receptors (ArSSR1–3) that we have character-
ized here as receptors for ArSS2. We speculate, therefore, that
ArSS1 and orthologues of ArSS1 in other echinoderms may
act via receptors that are distinct from the family of SS/
ASTC-type GPCRs (including ArSSR1–3) that have been
characterized in bilaterians. Further studies will be needed
to address this issue.4.2. Functional characterization of ArSS2 in the starfish
A. rubens
Having identified ArSS2 as the ligand for three SS/ASTC-type
receptors in A. rubens, we then investigated the expression
and pharmacological actions ofArSS2 to obtain the first insights
into the physiological roles of a SS/ASTC-type neuropeptide in
a deuterostome invertebrate. The use ofmRNA in situ hybridiz-
ation and immunohistochemistry revealed that cells/fibres
expressing ArSSP2 transcripts and ArSS2, respectively, are pre-
sent in the central nervous system, digestive system and the
body wall and its associated appendages (e.g. tube feet) of A.
rubens. This pattern of expression can be interpreted with refer-
ence to knowledge of the anatomy of the starfish nervous
system [71,79] and in comparison with the distribution of
other neuropeptides in A. rubens [63,67,72,80–84]. Thus, the
presence of ArSS2 in the various organ systems of A. rubens is
broadly similar to other neuropeptides, but there are specific
local differences in patterns of neuropeptide expression.
In common with other neuropeptides (e.g. the calcitonin-
type neuropeptide ArCT [83]), ArSS2 is expressed by neurons
in both the ectoneural region (containing sensory and
interneurons) and the hyponeural region (containing moto-
neurons) of the radial nerve cords and circumoral nerve ring,
which contrasts with neuropeptides that are only expressed
in the ectoneural region (e.g. the vasopressin/oxytocin-
type neuropeptide asterotocin) [67]. Based on this pattern
of expression, we can infer that ArSS2 acts as a signalling
molecule in the ectoneural region of the central nervous
system in A. rubens, but further studies will be required
to determine more specifically its roles. Furthermore, the
expression of ArSS2 in hyponeural motoneurons is indicative
of roles in neuromuscular signalling.
ArSS2 was detected in cells and processes in body wall-
associated muscular organs that enable locomotion in starfish
(tube feet) and in muscle-containing regions of the digestive
system (cardiac stomach). These findings provided a basis for
testing ArSS2 as a potential myoactive neuropeptide. ArSSP2
transcripts are detected in cells located along the length of
tube foot podia and ArSS2-immunoreactivity is present in
the subepithelial nerve plexus of tube foot podia. Consistent
with this expression of ArSS2 in tube feet, in vitro pharmaco-
logical tests revealed that ArSS2 causes dose-dependent
relaxation of tube foot preparations. Furthermore, expression
of ArSS2 in the disc region of tube feet is of interest because
of its role in secreting proteins that enable attachment to and
detachment from the substratum [85]. Thus, ArSS2 and other
neuropeptides expressed in the disc region [67,80–83] may be
involved in neural control of the secretion of these proteins.
Consistent with the expression of ArSS2 in the tube feet, an
extensive population of immunostained cells and fibres were
royalsocietypublishing.org/journal/rsob
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at the tip of each in arm and in its associated sensory organs,
which include lateral lappets (presumptive olfactory organs)
and the optic cushion (simple eye) [86,87]. Interestingly, there
is evidence that SS/ASTC-type neuropeptides are evolutiona-
rily ancient regulators of circadian activity [32,88,89] and
therefore the expression of ArSS2-expressing cells in the photo-
receptor cell layer of the optic cushion in A. rubens may be
evidence of this role in starfish.
ArSS2 is widely expressed in the digestive system of
A. rubens, including the peristomial membrane, cardiac
stomach, pyloric stomach, pyloric duct, and pyloric caeca. In
the cardiac stomach, ArSSP2 transcripts are detected in cells
located in themucosa layer andArSS2-immunoreactivity is pre-
sent in the adjacent basi-epithelial nerve plexus. Consistentwith
this expression of ArSS2 in the cardiac stomach, ArSS2 causes
dose-dependent relaxation of cardiac stomach preparations.
Other neuropeptides that cause relaxation of tube foot and/
or cardiac stomach preparations have been identified in
A. rubens, which include the SALMFamide neuropeptides S1
and S2 [64,66], pedal peptide/orcokinin-type neuropeptides
[81,82], the calcitonin-type neuropeptide ArCT [83] and the
vasopressin/oxytocin-type neuropeptide asterotocin [67].
Therefore, using the cardiac stomach as a test preparation, we
compared the efficacy of ArSS2 as a cardiac stomach relaxant
with two of these neuropeptides—S2 and asterotocin. This
revealed that at a concentration of 10−7 M, the efficacy of
ArSS2 was 1.5 times greater than that of S2, but only 44% of
the effect of asterotocin. At 10−6 M, there was no significant
difference in the efficacy of ArSS2 and S2, but the efficacy of
these peptides was approximately 50% of that of asterotocin
(figure 11). A previous study revealed that asterotocin is
much more effective as a cardiac stomach relaxant than S2
[67] and here, we show that asterotocin is more effective than
both S2 and ArSS2 as a cardiac stomach relaxant when tested
at 10−7 or 10−6 M.
The in vitro relaxing effect of ArSS2 on the cardiac stomach
of A. rubens is of interest from a physiological/behavioural
perspective because relaxation of the cardiac stomach is
required for the extraoral feeding behaviour of starfish where
it is everted out of the mouth and over the digestible soft
tissue of prey such as mussels [68,69]. Therefore, here,
we investigated the effect of in vivo injection of ArSS2 in
A. rubens and found that it causes partial eversion of the cardiac
stomach. Our previous studies have revealed that both S2 and
asterotocin also cause cardiac stomach eversion in A. rubens
but, consistent with their relative efficacy as cardiac stomach
relaxants in vitro, asterotocin is much more effective and
potent than S2 in triggering cardiac stomach eversion [67].
Accordingly, here, we found that asterotocin is much more
effective than ArSS2 in triggering cardiac stomach eversion,
consistent with their relative effectiveness as cardiac stomach
relaxants in vitro. Nevertheless, we conclude that ArSS2 is
one of several neuropeptide types that may participate in
physiological mechanisms associated with control of cardiac
stomach eversion during feeding in A. rubens.
Finally, it should be noted that ArSS2 did not cause relax-
ation when tested on preparations of the apical muscle,
which is located along the aboral coelomic lining of starfish
arms. Accordingly, we did not detect expression of ArSS2 in
the apical muscle. These findings are consistent with our
results from testing other neuropeptides in A. rubens, which
have revealed that while some neuropeptides cause relaxationof cardiac stomach, tube foot and apical muscle preparations
(e.g. the pedal peptide-type neuropeptide ArPPLN1b [81]),
other neuropeptides cause relaxation of only one or two of
these preparations. For example: (i) the vasopressin-type
neuropeptide asterotocin caused relaxation of cardiac stomach
and apical muscle preparations but not tube feet [67]; (ii) the
calcitonin-type neuropeptide ArCT caused relaxation of
apical muscle and tube foot preparations but not cardiac
stomach [83]; (iii) the pedal peptide-type neuropeptide
ArPPLN2 h caused relaxation of cardiac stomach preparations
but not tube feet or apical muscle [82]; and (iv) the luqin-
type neuropeptide ArLQ caused relaxation of tube foot
preparations but not cardiac stomach or apical muscle [63].
Further insights into the physiological significance of these
differences in the actions of neuropeptides that act as muscle
relaxants in starfish may be obtained by detailed comparative
analysis of the expression of the receptors that mediate
their effects.
4.3. Evolutionary and comparative physiology of SS/
ASTC-type neuropeptide signalling in the Bilateria
Our discovery that ArSS2 acts as a muscle relaxant in
A. rubens is noteworthy because it provides the first insight
into the physiological roles of SS-type neuropeptides in a
deuterostome invertebrate. A common theme emerging
from investigations of the physiological roles of SS-type
neuropeptides in vertebrates and ASTC-type neuropeptides
in protostome invertebrates is that they typically act as inhibi-
tory regulators of physiological processes at the level of cells,
tissues or organs. For example, SS inhibits gut motility [8,9]
and hormone secretion [1] in mammals and ASTC inhibits
cardiac and gut activity [30,33] and hormone synthesis [23]
in insects. Therefore, our discovery that an SS-type neuropep-
tide (ArSS2) acts as a myoinhibitory agent (muscle relaxant)
in an echinoderm (A. rubens) is consistent with the inhibitory
actions of SS/ASTC-type neuropeptides in other taxa.
Accordingly, our findings combined with previous findings
from vertebrates and arthropods indicate that the role of
SS/ASTC-type neuropeptides as inhibitory regulators of
physiological processes can be traced back to the urbilaterian
common ancestor deuterostomes and protostomes. However,
while the actions of SS/ASTC-type neuropeptides at the cell/
tissue/organ level are typically inhibitory, at a systems/
behavioural level, this may manifest as an inhibitory or a
stimulatory action. For example, injection of an ASTC-type
peptide inhibits foregut motility, food intake and growth in
larval tomato moth L. oleracea [33]. By contrast, SS stimulates
food intake and drinking in mammals, which involves com-
plex interactions with other neuronal signalling systems in
the brain that regulate feeding/drinking [90]. Accordingly,
the inhibitory action of ArSS2 in causing cardiac stomach
relaxation may manifest at a behavioural level in triggering
the dynamic process of cardiac stomach eversion when
starfish feed.5. Conclusion
We have obtained the first insights into the molecular proper-
ties and physiological roles of SS-type neuropeptide signalling
in a deuterostome invertebrate—the starfishA. rubens (phylum
Echinodermata). Discovery of an SS-type signalling system in
royalsocietypublishing.org/journal/rsob
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3 provides a missing link in our knowledge of the molecular
evolution of SS/ASTC-type signalling in the Bilateria. Our
finding that ArSS2 acts as a muscle relaxant in A. rubens pro-
vides new evidence that SS/ASTC-type neuropeptides have
an evolutionarily ancient and conserved role as inhibitory reg-
ulators of physiological processes in the Bilateria. Furthermore,
the in vivo effect of ArSS2 in triggering stomach eversion in
A. rubens is indicative of an evolutionarily ancient and con-
served role of SS/ASTC-type neuropeptides as regulators of
feeding behaviour. However, given the widespread expression
of ArSS2 inA. rubens in the central nervous system and periph-
eral organ systems, it is likely that ArSS2 is a pleiotropic
peptide and also has other roles. For example, the expression
of ArSS2 by neurons in the ectoneural region of the radial
nerve cords and circumoral nerve ring is indicative of roles as
a neuromodulator and here parallels can be drawn with
the expression of SS in subpopulations of inhibitory GABA-
ergic neurons in cortical regions of the mammalian brain
[10,11]. Furthermore, as highlighted above, the expression
of ArSS2 by cells in the photoreceptor cell layer of the optic
cushion in A. rubens may be indicative of roles associated
with regulation of circadian activity. Clearly, further investi-
gation of the actions of ArSS2 in A. rubens will be required
to obtain broader insights into its physiological roles. Further-
more, although the receptor(s) that mediates the effects of
ArSS1 remains to be identified, it will also be of interest to
compare the expression and actions of ArSS1 and ArSS2 in
A. rubens. Likewise, investigation of the actions of both SS1-
type and SS2-type neuropeptides in sea cucumbers, brittle
stars and sea urchinswould provide a comparative perspective
on the physiological roles of SS/ASTC-type neuropeptides in
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